{Reference Type}: Editorial
{Title}: Toward Guideline-Directed Medical Therapy in Nephrology: Lifetime Benefit of RAAS and SGLT2 Inhibition in Nondiabetic Kidney Disease.
{Author}: Zeitler EM;Mottl AK;
{Journal}: Clin J Am Soc Nephrol
{Volume}: 17
{Issue}: 12
{Year}: 12 2022
{Factor}: 10.614
{DOI}: 10.2215/CJN.12401022